FDA’s Generic Drug Program in 2020 Helped Ensure Availability of High-Quality, Affordable Drugs Amid COVID-19

In 2020, the FDA’s generic drug program moved steadily forward even as the COVID-19 pandemic presented additional complexities, resulting in new realities and unique challenges.